Applications of nanomedicine in antibacterial medical therapeutics and diagnostics

Open Tropical Medicine Journal

Volumn 3, Issue 1, 2010, Pages 1-9

  Matthews, Liam ^a   Kanwar, Rupinder K ^a   Zhou, Shufeng ^b   Punj, Vasu ^c   Kanwar, Jagat R ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b RMIT UNIVERSITY   (Australia)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBON NANOTUBE; CERIUM OXIDE; CHITOSAN; CLINDAMYCIN; ERYTHROMYCIN; FULLERENE DERIVATIVE; GLASS; GOLD NANOPARTICLE; MAGNESIUM OXIDE; METAL OXIDE; NANOFIBER; NANOMATERIAL; NANOPARTICLE; PENICILLIN G; POLYLACTIC ACID; POLYMER; QUANTUM DOT; RIFAMPICIN; SILICON DIOXIDE; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE; VANCOMYCIN; ZINC OXIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERICIDAL ACTIVITY; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CARDIOTOXICITY; CLINICAL EFFECTIVENESS; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG TARGETING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HOSPITALIZATION; HUMAN; LUNG TOXICITY; MORTALITY; NANODEVICE; NANOFABRICATION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; TOXICITY TESTING;

EID: 77953407710     PISSN: None     EISSN: 18743153     Source Type: Journal    
DOI: 10.2174/1874315301003010001     Document Type: Review

References (49)

1. Chun YW, Webster TJ. The role of nanomedicine in growing tissues. Ann Biomed Eng 2009; 37(10): 2034-47.
2. Weir E, Lawlor A, Whelan A, Regan F. The use of nanoparticles in anti-microbial materials and their characterization. Analyst 2008; 133(7): 835-45.
3. Pedroso S, Guillen IA. Microarray and nanotechnology applications of functional nanoparticles. Comb Chem High Throughput Screen 2006; 9(5): 389-97.
4. Kanwar J R, Mahidhara G, Kanwar R K. Recent advances in nanoneurology for drug delivery to the brain. Curr Nanosci 2009; 5(4): 441-8.
5. Sara B, Kanwar RK, Khoshmanesh K, et al. Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases Currt Nanosci 2009; 5(1): 26-32.
6. Yacoby I, Benhar I. Antibacterial nanomedicine. Nanomed 2008; 3(3): 329-41.
7. Seoktae K. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 2007; 23(17): 8670-3.
8. Chipot C, Tarek M. Interaction of a peptide nanotube with a watermembrane interface. Phys Biol 2006; 3(1): p S20-5.
9. Lyon DY, Fortner JD, Sayes CM, Colvin VL, Hughe JB. Bacterial cell association and antimicrobial activity of a C60 water suspension. Environ Toxicol Chem 2005; 24(11): 2757-62.
10. Moghimi SM. Nanomedicine: prospective diagnostic and therapeutic potentials. Asia Pacific Biotech News 2005; 9(20): 1072-7.
11. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E coli as a model for Gram-negative bacteria. J Coll Inter Sci 2004; 275(1): 177-82.
12. Shahverdi AR. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli Nanomedicine. Nanotech Biol Med 2007; 3(2): 168-71.
13. Waltimo T. Antimicrobial effect of nanometric bioactive glass 45S5. J Dent Res 2007; 86(8): 754.
14. Stoimenov PK. Metal oxide nanoparticles as bactericidal agents. Langmuir 2002; 18(17): 6679-86.
15. Huang L. Controllable preparation of Nano-MgO and investigation of its bactericidal properties. J Inorg Biochem 2005; 99(5): 986-93.
16. Jones N. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms FEMS. Microbiol Lett 2008; 279(1): 71-6.
17. Anglin EJ. Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev 2008; 60(11): p 1266-77.
18. Jia H. The structures and antibacterial properties of nano-SiO2 supported silver/zinc silver materials. Dent Mater 2008; 24(2): 244-9.
19. Prabaharan M. Review Paper: Chitosan derivatives as promising materials for controlled. Drug Deliv J Biomat Applicat 2008; 23(1): 5-36.
20. Ignatova M. Electrospun nano-fibre mats with antibacterial properties from quaternised chitosan and poly(vinyl alcohol). Carbohydr Res 2006; 341(12): 2098-107.
21. Yacoby I. Targeted Drug-Carrying bacteriophages as antibacterial nanomedicines. Antimic Agents Chemother 2007; 51(6): 2156-63.
22. Bar H, Yacoby I, Benhar I. Killing cancer cells by targeted drugcarrying phage nanomedicines. BMC Biotechnol 2008; 8: 37.
23. Fischetti VA. Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 2005; 13(10): 491-6.
24. Dixon B. New dawn for phage therapy. Lancet Infect Dis 2004; (3): 186.
25. Merril CR, Scholl D, Adhya SL. The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2003; 2(6): 489-97.
26. Rippon JE. A new serological division of Staphylococcus aureus bacteriophages: group G. Nature 1952; 16170(4320): 287.
27. 2 anti-solvent precipitation for sustained antimicrobial activity. Int J Pharma 2004; 287(1/2): 163-73.
28. Faulk WP, Taylor GM. An immunocolloid method for the electron microscope. Immunochemistry 1971; 8(11): 1081-3.
29. Baptista P, Pereira E, Eaton P, et al. Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem 2008; 391(3): 943-50.
30. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications Adv Drug Deliv Rev 2008; 60(11): 1307-15.
31. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108(6): 2064-110.
32. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009; 38(6): 1759-82.
33. Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomedicine 2007; 3(2): 161-7.
34. Hahn MA, Tabb JS, Krauss TD. Detection of single bacterial pathogens with semiconductor quantum dots. Anal Chem 2005; 77(15): 4861-9.
35. Edgar R, MsKinstry M, Hwang J, et al. High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes. Proc Natl Acad Sci USA 2006; 103(13): 4841-5.
36. Dwarakanath S. Quantum dot-antibody and aptamer conjugates shift fluorescence upon binding bacteria. Biochem Biophys Res Commun 2004; 325(3): 739-43.
37. Tallury P, Payton K, Santra S. Silica-based multimodal/ multifunctional nanoparticles for bioimaging and biosensing applications. Nanomed 2008; 3(4): 579-92.
38. Yan J, Estévez MC, Smith JE, et al. Dye-doped nanoparticles for bioanalysis. Nano Today 2007; 2(3): 44-50.
39. Gang Y. FloDots: luminescent nanoparticles. Anal Bioanal Chem 2006; 385(3): 518-24.
40. Wang L. Fluorescent nanoparticles for multiplexed bacteria monitoring. Bioconj Chem 2007; 18(2): 297-301.
41. Kim JW, Shashkov EV, Galanzha EI, Kotagiri N, Zharov VP. Photothermal antimicrobial nanotherapy and nanodiagnostics with self-assembling carbon nanotube clusters. Lasers Surg Med 2007; 39 (7): 62-634.
42. Zharov VP. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J 2006; 90(2): 619-62.
43. Bindu MN, Muhammed STK, Wojciech GL, et al. Toxicity evaluation of gold - dendrimer composite nanodevices invitro - difference found between tumour and proliferating endothelial cells. Nanotoxicology 2009; 3(2): 139-51.
44. Melanie A, Jerome R, Thierry O, et al. CeO2 Nanoparticles Induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 2009; 3(2): 161-71.
45. Silva GA. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Surg Neurol 2007; 67: 113-6.
46. Ochekpe NA, Olorunfemi PO, Ngwuluka NC. Nanotechnology and drug delivery part 1: background and applications. Trop J Pharma Res 2009; 8(3): 265-74.
47. Dwivedi PD, Misra A, Shanker R, Das M. Are nanomaterials a threat to the immune system? Nanotoxicology 2009; 3(1): 19-26.
48. Bharali D, Khalil M, Gurbuz M, Simone TM, Mousa SA. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomed 2009; 4: 1-7.
49. Gonzalez L, Lison D, Kirsch-Volders M. Genotoxicity of engineered nanomaterials: a critical review. Nanotoxicology 2008; 2(4): 252-73.